{"id":7959,"date":"2011-04-23T09:54:26","date_gmt":"2011-04-23T13:54:26","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=7959"},"modified":"2011-04-23T10:10:00","modified_gmt":"2011-04-23T14:10:00","slug":"personalized-medicine-along-the-hudson","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2011\/04\/23\/personalized-medicine-along-the-hudson\/","title":{"rendered":"personalized medicine: and along the hudson&#8230;"},"content":{"rendered":"\n<div align=\"justify\"><img loading=\"lazy\" decoding=\"async\" width=\"176\" hspace=\"4\" height=\"159\" border=\"0\" align=\"right\" src=\"http:\/\/www.procolharum.com\/tn+sq\/mightymouse.gif\" \/>Who could forget TerryTune&#8217;s <strong><font color=\"#200020\">Mighty Mouse<\/font><\/strong>, the Superhero from the 1940s? Well he&#8217;s urgently needed in TarryTown NY to save the mice from <u><a target=\"_blank\" href=\"http:\/\/www.psychogenics.com\/index.htm\"><strong><font color=\"#0077aa\">Psycho<em>Genics<\/em> Inc<\/font><\/strong><\/a><\/u>. <\/div>\n<ul>\n<div align=\"justify\"><sup><strong><font color=\"#0077aa\">Psycho<em>Genics<\/em> Inc<\/font><\/strong>, a leader in preclinical neurobiology and in the provision  of CNS drug discovery solutions, works with pharmaceutical companies and  not-for-profit organizations to validate targets and select compounds  to advance into clinical trials.&nbsp; <strong><font color=\"#0077aa\">Psycho<em>Genics<\/em> Inc<\/font><\/strong> transforms drug discovery  by combining expertise in behavioral neurobiology with the power of  bioinformatics in conjunction with proprietary, high-throughput  behavioral testing platforms that rapidly screen compound libraries for  CNS activity.<\/sup><\/div>\n<\/ul>\n<div align=\"justify\"><a target=\"_blank\" href=\"http:\/\/www.psychogenics.com\/index.htm\"><strong><font color=\"#0077aa\">Psycho<em>Genics<\/em> Inc<\/font><\/strong><\/a> takes things up a notch from <strong><font color=\"#660033\">Brain Resources<\/font><\/strong> in the world of <strong><font color=\"#200020\">personalized medicine<\/font><\/strong>:   <\/div>\n<ol>\n<div align=\"justify\"><sup>PsychoGenics  supports development of the next generation of drugs to treat CNS  disorders by providing a broad range of target screening, discovery and  validation resources to pharmaceutical and biotech companies, academic  institutions and not-for-profit research foundations. Business  agreements range from consulting and designing drug discovery  strategies, to fee-for-service testing, to onsite research training and  management.<\/sup><\/div>\n<div align=\"justify\"><sup>The company has  approximately 140 research and support staff, of which more than 35  have Ph.D.s and oversee the offered 50 validated in vivo behavioral  tests. PsychoGenics is constantly updating its services by developing  new behavioral models and approaches to behavioral testing. <\/sup><\/div>\n<div><strong><font color=\"#200020\"><sup>Services include:<\/sup><\/font><\/strong><\/div>\n<ul>\n<div><sup>&bull; Breeding          <\/sup><\/div>\n<div><sup>&bull; Genotyping          <\/sup><\/div>\n<div><sup>&bull; Behavioral Pharmacology          <\/sup><\/div>\n<div><sup>&bull; Phenotyping          <\/sup><\/div>\n<div><sup>&bull; Microdialysis          <\/sup><\/div>\n<div><sup>&bull; Radiotelemetry <\/sup><\/div>\n<\/ul>\n<div align=\"justify\"><sup><strong><font color=\"#200020\">Customized Services:<\/font><\/strong> PsychoGenics  has established protocols and Standard Operating Procedures for the  array of pharmacologically validated tests it offers. The company is  also flexible and can modify protocols and establish new tests to  address client needs. Client work will not proceed until all tests pass  PsychoGenics&#8217; stringent validation requirements.  <\/sup><\/div>\n<div align=\"justify\"><sup><strong><font color=\"#200020\">Clients:<\/font><\/strong> PsychoGenics  has relationships with more than  100 pharmaceutical and biotech  companies, and not-for-profit institutions, including Astra Zeneca, Eli  Lilly &amp; Company, Sepracor, F. Hoffmann-La Roche, Lundbeck, Harvard  Medical School\/Massachusetts General Hospital, the ALS Association, SMA  Foundation and CHDI. Eighty five percent of the company&#8217;s current  business is repeat business.<\/sup><\/div>\n<div align=\"justify\"><sup><strong><font color=\"#200020\">Research Staff:<\/font><\/strong> The vast  majority of PsychoGenics&#8217; research staff has extensive pharmaceutical  experience; thirty-five of whom have Ph.Ds. All research staff are  highly trained in GLP standards and training records are available to  our clients. Training is overseen by a GLP-trained Director of Quality  Control and Safety.   Among PsychoGenics&#8217; areas of expertise is mouse behavior, including  knowledge of the behavioral and neurological characteristics of the  strains most commonly used to produce transgenic mice.  Most of the  tests in PsychoGenics&#8217; recommended battery of behavioral assays have  been studied in multiple strains of mice and rats.  <\/sup><\/div>\n<\/ol>\n<div align=\"justify\">And don&#8217;t miss the <u><a target=\"_blank\" href=\"http:\/\/www.psychogenics.com\/ldr-board-of-directors.shtml\"><strong><font color=\"#200020\">Members of the Board<\/font><\/strong><\/a><\/u> and the <u><a target=\"_blank\" href=\"http:\/\/www.psychogenics.com\/ldr-sab.shtml\"><strong><font color=\"#200020\">Scientific Advisors<\/font><\/strong><\/a><\/u>. <strong><font color=\"#200020\">Eric Nestler<\/font><\/strong> from Mount Sinai is there [formerly the Chairman from the Texas Department that brought us STAR*D and TMAP]. <strong><font color=\"#200020\">Maurice Fava<\/font><\/strong> from Harvard [and STAR*D] is on board along with Nobel Laureate, <strong><font color=\"#200020\">Paul Greengard<\/font><\/strong>. And Columbia&#8217;s walk-about Chairman, <strong><font color=\"#200020\">Jeffrey Lieberman<\/font><\/strong>, is right there as always. All you have to do is supply the compound and pay your bills. <strong><font><strong><font color=\"#0077aa\">Psycho<em>Genics<\/em> Inc<\/font><\/strong><\/font><\/strong> will figure out if has any psychopharmacologic qualities and where to use it. It looks as if they&#8217;ve really loaded the science side, including Radiotelemetry [in case their mice get lost?].<\/div>\n<p align=\"justify\">The trinity of <strong><font color=\"#200020\">evidence-based medicine<\/font><\/strong>, <strong><font color=\"#200020\">translational medicine<\/font><\/strong>, and <strong><font color=\"#200020\">personalized medicine<\/font><\/strong> are coming together just in time to meet the challenges of the patent expirations over the next few years. With an empty pharmaceutical pipeline, and the age of SSRIs and Atypical Antipsychotics coming to a close, a generation of neurobiologists is aiming to consummate the marriage of academic psychiatry to the pharmaceutical industry, and continue their lucrative march into a brave new world.  <\/p>\n<div align=\"justify\">Only Mighty Mouse stands in the way&#8230;<\/div>\n<div align=\"right\"><sup>hat tip to <strong>SteveBMD<\/strong><\/sup><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Who could forget TerryTune&#8217;s Mighty Mouse, the Superhero from the 1940s? Well he&#8217;s urgently needed in TarryTown NY to save the mice from PsychoGenics Inc. PsychoGenics Inc, a leader in preclinical neurobiology and in the provision of CNS drug discovery solutions, works with pharmaceutical companies and not-for-profit organizations to validate targets and select compounds to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-7959","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/7959","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=7959"}],"version-history":[{"count":25,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/7959\/revisions"}],"predecessor-version":[{"id":7984,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/7959\/revisions\/7984"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=7959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=7959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=7959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}